New diabetes combo pill aims to lower blood sugar in patients failing metformin
NCT ID NCT07229534
First seen Nov 17, 2025 · Last updated May 01, 2026 · Updated 17 times
Summary
This study tests a new medicine called DA-5218 in 238 adults with type 2 diabetes whose blood sugar is still too high despite taking metformin. Participants will receive either DA-5218 or an active comparator to see which better lowers HbA1c over 8 weeks. The goal is to improve blood sugar control without causing serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.